Benjamin Burnett
Stock Analyst at Stifel
(1.61)
# 3,278
Out of 4,944 analysts
68
Total ratings
41.67%
Success rate
-6.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $0.94 | +220.41% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $56.60 | -13.43% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $72.50 | +68.28% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $16.86 | +309.25% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $23.62 | +187.95% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.03 | +346.60% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $11.54 | +398.27% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $4.38 | +17,708.22% | 2 | Sep 10, 2021 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $35.26 | +81.51% | 5 | Apr 1, 2025 | |
| IRON Disc Medicine | Maintains: Buy | $90 → $94 | $58.98 | +59.38% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.56 | +156.41% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.80 | +455.56% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.23 | +1,021.08% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $330 → $360 | $23.60 | +1,425.42% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.52 | +2,991.79% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $0.94
Upside: +220.41%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $56.60
Upside: -13.43%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $72.50
Upside: +68.28%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $16.86
Upside: +309.25%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $23.62
Upside: +187.95%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.03
Upside: +346.60%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $11.54
Upside: +398.27%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $4.38
Upside: +17,708.22%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $35.26
Upside: +81.51%
Disc Medicine
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $58.98
Upside: +59.38%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.56
Upside: +156.41%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.80
Upside: +455.56%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $2.23
Upside: +1,021.08%
Jun 28, 2021
Upgrades: Buy
Price Target: $330 → $360
Current: $23.60
Upside: +1,425.42%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.52
Upside: +2,991.79%